Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Global Regulatory Systems01:28

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Hazard Analysis and Critical Control Points (HACCP)01:30

Hazard Analysis and Critical Control Points (HACCP)

Hazard Analysis and Critical Control Points (HACCP) is a science-based, preventive system used globally to ensure food safety by identifying, evaluating, and controlling biological, chemical, and physical hazards throughout food production. Originally developed by NASA and the Pillsbury Company for astronaut food, HACCP is now a core component of the Codex Alimentarius.HACCP operates on prerequisite programs—such as Good Manufacturing Practices (GMPs), sanitation procedures, and supplier...
Three-Dimensional Force System:Problem Solving01:30

Three-Dimensional Force System:Problem Solving

A three-dimensional force system refers to a scenario in which three forces act simultaneously in three different directions. This type of problem is commonly encountered in physics and engineering, where it is necessary to calculate the resultant force on the system, which can then be used to predict or analyze the behavior of the object or structure under consideration.
To solve a three-dimensional force system, first resolve each force into its respective scalar components. Do this using...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization of the mouse bioassay for deoxynivalenol as an alternative to large animal studies.

Bulletin of environmental contamination and toxicology·1994
Same author

Effects of dietary fat source on sudden death syndrome and cardiac sarcoplasmic reticular calcium transport in broiler chickens.

Poultry science·1993
Same author

Investigations in the use of mice exposed to mycotoxins as a model for growing pigs.

Journal of toxicology and environmental health·1992
Same author

Influence of dietary charcoal on ochratoxin A toxicity in Leghorn chicks.

Canadian journal of veterinary research = Revue canadienne de recherche veterinaire·1989
Same author

Estimation of apparent protein digestibility using uric acid-corrected nitrogen values in poultry excreta.

Poultry science·1989
Same journal

[The progress of participation research. A sociological analysis of its institutionalization].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Applying the German demand planning guideline to maternity care provision: regional and socioeconomic disparities].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Medical aids for children and adolescents following the legislative change-a status report].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Doping: caught between fraud, health protection, and responsibility].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Aging with intellectual and developmental disabilities or severe multiple disabilities-health, participation, and care in later life].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Sexual self-determination and disability: 10 years of the ReWiKs project-dynamics and findings].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
See all related articles

Related Experiment Videos

[The global harmonization task force : successes and challenges].

R G Rotter1

  • 1Global Harmonization Task Force, c/o Medical Devices Bureau, Health Canada , Add. Loc. 0301H1, K1A 0K9, Ottawa, Ontario, Canada. roland_rotter@hc-sc.gc.ca

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|May 7, 2009
PubMed
Summary
This summary is machine-generated.

The Global Harmonization Task Force (GHTF) developed a unified model for medical device regulation. This harmonization aims to enhance device safety, quality, and trade globally.

Related Experiment Videos

Area of Science:

  • Regulatory Science
  • International Trade Law
  • Public Health Policy

Context:

  • Globalization of commerce necessitates harmonized medical device regulations.
  • Existing regulatory frameworks present barriers to international trade and patient safety.
  • The Global Harmonization Task Force (GHTF) was established to address these challenges.

Purpose:

  • To promote convergence of medical device regulatory requirements globally.
  • To ensure the safety, quality, and effectiveness of medical devices worldwide.
  • To foster international trade and facilitate information exchange among regulatory bodies.

Summary:

  • The GHTF, through its Steering Committee and Study Groups, has developed a comprehensive global model for medical device regulation.
  • This model is the result of collaborative efforts since 1992, aiming for consensus-based regulatory practices.
  • The initiative seeks to balance public health protection with the promotion of technological innovation and trade.

Impact:

  • Establishes a framework for consistent medical device oversight across nations.
  • Facilitates smoother international trade by reducing regulatory disparities.
  • Ultimately aims to enhance public health by ensuring access to safe and effective medical devices.